CBD Science looks to raise £2M in Series A to advance its plant-based cannabinoid therapy in the UK September 25, 2021 guardianso CBD 0 CBD Science Group PLC CEO Dr Michael Raymont joined Proactive New York to discuss the London, England-based group’s Series A funding round, on the …
Leave a Reply